Share Prices & Company Research

Stockbroking

Creo Medical Group

Current Price 206.92p Bid 203.00p Ask 210.00p Change 0.00%
Last Updated: 25/05/2019 22:26. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Creo Medical Group plc, founded in 2003, is a medical device company focused on the development and commercialisation of minimally invasive surgical devices, by bringing advanced energy to endoscopy. The Company's mission is to improve patient outcomes by applying microwave and RF energy to surgical endoscopy. Creo has developed CROMA, an electrosurgical advanced energy platform that combines bipolar radiofrequency for precise localised cutting and microwave for controlled coagulation. This technology provides clinicians with flexible, accurate and controlled surgical solutions. The Company's strategy is to bring its CROMA platform to market through a suite of medical devices which the Company has designed, initially for the emerging field of GI therapeutic endoscopy, an area with high unmet needs. The CROMA platform will be developed further for bronchoscopy and laparoscopy procedures. The Company believes its technology can impact the landscape of surgery and endoscopy by providing a safer, less-invasive and more cost-efficient option of treatment.

Financial Highlights Year Ended 31/12/2018

Turnover
£0.00m
Operating Profit
£-17.66m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-12.91

Key Personnel

Craig Jonathan Gulliford
Chief Financial Officer
Richard John Rees
Chief Financial Officer
Dr Christopher Paul Hancock
Chief Technology Officer
Charles Alexander Evan Spicer
Non-Executive Chairman
John Bradshaw
Non-Executive Director
David Gerard Woods
Non-Executive Director

Stock Details

EPIC
CREO
ISIN
GB00BZ1BLL44
Shares in Issue
121,543,585
Market cap
£250.99m

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
206.50p
Bid Price
203.00p
Ask Price
210.00p
Volume
2730
Change Today
0.00p
% Change Today
0.00%
Open
207.00p
Previous Close
206.50p
Intraday High
207.00p
Intraday Low
206.92p
52 Week High
250.00p
52 Week Low
122.50p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Creo Medical Group Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
30 Jun 2017
Tangible Assets
0.9
0.3
Intangible Assets & Goodwill
0.3
0.0
Investments & Other Non-Current Assets
0.0
0.0
Total Non-Current Assets
1.2
0.4
Inventory
0.3
0.1
Trade & Receivables
1.1
0.5
Cash & Receivables
44.6
13.7
Other Current Assets & Assets Held for Resale
2.6
1.5
Total Assets
49.8
16.1

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
30 Jun 2017
Short Term Liabilities
1.6
1.5
Long Term Liabilities
0.4
0.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
2.0
1.5

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
30 Jun 2017
Net Assets
47.7
14.7

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
30 Jun 2017
Share Capital
0.1
0.1
Minority Interests
0.0
0.0
Retained Earnings
-34.9
-20.1
Share Premium Account
65.8
19.8
Other Equity
16.7
14.9
Total Equity
47.7
14.7

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
30 Jun 2017
Cashflow from Operating Activities
-14.3
-6.9
Cashflow Before Financing
-15.6
-7.1
Increase / Decrease in Cash
30.9
12.9

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
30 Jun 2017
Turnover
0.0
0.0
Cost of Sales
0.0
0.0
Gross Profit
0.0
0.0
Operating Profit
-17.7
-8.9
Pre-Tax Profit
-17.6
-8.9
Profit / Loss for the Year
-14.8
-7.8
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.